Helixgate

Helixgate

Uncategorized

CSL sinks to nine-year low on revenue warning, $5B write-down

CSL sinks to nine-year low on revenue warning, $5B write-down

Published

on

CSL’s stock hit its lowest price since early 2017 on Monday after it lowered its full-year revenue guidance by about 4% and said it would have to take a new $5 billion impairment charge.

The …​ ​Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

The connection between periods and mental health

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Good morning and happy Monday. Lots of infectious disease reading today, and some political movement, too. I hope your coffee is ready.

Read the rest…

Read More

Published

on

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Good morning and happy Monday. Lots of infectious disease reading today, and some political movement, too. I hope your coffee is ready.

Read the rest…

Read More

Continue Reading

Uncategorized

Makary’s reported FDA removal could be ‘broad positive’ for biopharma

Published

on

The widely covered impending ouster of FDA Commissioner Marty Makary not long after the exit of controversial biologics head Vinay Prasad highlights the severe turnover rates at the highest rungs of leadership at the health department.

Continue Reading

Uncategorized

Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher

Published

on

Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.

Continue Reading
Advertisement

Trending